Thomas Scriba
Thomas Scriba
Verified email at - Homepage
Cited by
Cited by
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
MD Tameris, M Hatherill, BS Landry, TJ Scriba, MA Snowden, S Lockhart, ...
The Lancet 381 (9871), 1021-1028, 2013
A blood RNA signature for tuberculosis disease risk: a prospective cohort study
DE Zak, A Penn-Nicholson, TJ Scriba, E Thompson, S Suliman, LM Amon, ...
The Lancet 387 (10035), 2312-2322, 2016
Identifying specificity groups in the T cell receptor repertoire
J Glanville, H Huang, A Nau, O Hatton, LE Wagar, F Rubelt, X Ji, A Han, ...
Nature 547 (7661), 94-98, 2017
Immunological biomarkers of tuberculosis
G Walzl, K Ronacher, W Hanekom, TJ Scriba, A Zumla
Nature Reviews Immunology 11 (5), 343-354, 2011
Distinct, specific IL-17-and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response
TJ Scriba, B Kalsdorf, DA Abrahams, F Isaacs, J Hofmeister, G Black, ...
The Journal of Immunology 180 (3), 1962-1970, 2008
Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns
BMN Kagina, B Abel, TJ Scriba, EJ Hughes, A Keyser, A Soares, ...
American journal of respiratory and critical care medicine 182 (8), 1073-1079, 2010
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
E Nemes, H Geldenhuys, V Rozot, KT Rutkowski, F Ratangee, N Bilek, ...
New England Journal of Medicine 379 (2), 138-149, 2018
T cells and adaptive immunity to Mycobacterium tuberculosis in humans
LD Jasenosky, TJ Scriba, WA Hanekom, AE Goldfeld
Immunological reviews 264 (1), 74-87, 2015
Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
O Van Der Meeren, M Hatherill, V Nduba, RJ Wilkinson, M Muyoyeta, ...
New England Journal of Medicine 379 (17), 1621-1634, 2018
Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles
AP Soares, TJ Scriba, S Joseph, R Harbacheuski, RA Murray, ...
The Journal of Immunology 180 (5), 3569-3577, 2008
Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells
LJ Walker, YH Kang, MO Smith, H Tharmalingham, N Ramamurthy, ...
Blood, The Journal of the American Society of Hematology 119 (2), 422-433, 2012
T-cell activation is an immune correlate of risk in BCG vaccinated infants
HA Fletcher, MA Snowden, B Landry, W Rida, I Satti, SA Harris, ...
Nature communications 7 (1), 1-11, 2016
Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells
TJ Scriba, M Tameris, N Mansoor, E Smit, L van der Merwe, F Isaacs, ...
European journal of immunology 40 (1), 279-290, 2010
Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
DR Tait, M Hatherill, O Van Der Meeren, AM Ginsberg, E Van Brakel, ...
New England Journal of Medicine 381 (25), 2429-2439, 2019
COMPASS identifies T-cell subsets correlated with clinical outcomes
L Lin, G Finak, K Ushey, C Seshadri, TR Hawn, N Frahm, TJ Scriba, ...
Nature biotechnology 33 (6), 610-616, 2015
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa
T Hawkridge, TJ Scriba, S Gelderbloem, E Smit, M Tameris, S Moyo, ...
The Journal of infectious diseases 198 (4), 544-552, 2008
Four-gene pan-African blood signature predicts progression to tuberculosis
S Suliman, EG Thompson, J Sutherland, J Weiner 3rd, MOC Ota, ...
American journal of respiratory and critical care medicine 197 (9), 1198-1208, 2018
Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
E Petruccioli, TJ Scriba, L Petrone, M Hatherill, DM Cirillo, SA Joosten, ...
European Respiratory Journal 48 (6), 1751-1763, 2016
First-in-human trial of the post-exposure tuberculosis vaccine H56: IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults
AKK Luabeya, BMN Kagina, MD Tameris, H Geldenhuys, ST Hoff, Z Shi, ...
Vaccine 33 (33), 4130-4140, 2015
Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation
A Soares, L Govender, J Hughes, W Mavakla, M de Kock, C Barnard, ...
Journal of immunological methods 362 (1-2), 43-50, 2010
The system can't perform the operation now. Try again later.
Articles 1–20